Literature DB >> 16207592

Cyclin D1 gene polymorphism and susceptibility to childhood acute lymphoblastic leukemia in a Chinese population.

Xuwei Hou1, Sili Wang, Yuling Zhou, Ziliang Xu, Yao Zou, Xiaofan Zhu, Mingzhe Han, Tianxiang Pang, Zhong Chao Han.   

Abstract

Cyclin D1 is a key protein involved in cell cycle regulation. A common A870G single nucleotide polymorphism in exon 4 of the cyclin D1 gene (CCND1) has an effect on the transcription of 2 different cyclin D1 messenger RNAs. Correlation between genetic polymorphism of A870G of CCND1 and clinical outcome among patients with acute lymphoblastic leukemia (ALL) has been reported. However, the effect on ALL occurrence remains unclear. To examine the genotypic frequency of CCND1 polymorphism, we performed a case-control study in a Chinese population of 183 children with ALL and 190 healthy controls. The genetic frequency of CCND1 had a significant overall correlation in patients and controls. The AA genotype of CCND1 showed a tendency to increase ALL risk 3.2898-fold compared with the AG + GG genotype (P = .0207). Stratification of patients according to cell type, risk level, and chemotherapeutic response showed significance for the AA genotype in T-cell ALL, ALL with high risk, and no complete remission (P = .047, P = .011, and P = .007, respectively). No gene dosage effect was observed in this study. The results of the present study suggested that CCND1 genetic polymorphism may be related to the occurrence of ALL in a population of Chinese children.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16207592     DOI: 10.1532/IJH97.A10418

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  20 in total

Review 1.  Acute lymphoblastic leukemia: recent advances in biology and therapy.

Authors:  R Champlin; R P Gale
Journal:  Blood       Date:  1989-06       Impact factor: 22.113

Review 2.  Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression.

Authors:  Y Hosokawa; A Arnold
Journal:  Genes Chromosomes Cancer       Date:  1998-05       Impact factor: 5.006

3.  Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study.

Authors:  Y Zheng; H Shen; E M Sturgis; L E Wang; S A Eicher; S S Strom; M L Frazier; M R Spitz; Q Wei
Journal:  Carcinogenesis       Date:  2001-08       Impact factor: 4.944

4.  Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas.

Authors:  D J Simpson; A A Fryer; A B Grossman; J A Wass; M Pfeifer; J M Kros; R N Clayton; W E Farrell
Journal:  Carcinogenesis       Date:  2001-11       Impact factor: 4.944

5.  Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer.

Authors:  S Kong; C I Amos; R Luthra; P M Lynch; B Levin; M L Frazier
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

6.  CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer.

Authors:  S Bala; P Peltomäki
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

7.  Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative.

Authors:  J A McKay; J J Douglas; V G Ross; S Curran; G I Murray; J Cassidy; H L McLeod
Journal:  Int J Cancer       Date:  2000-10-01       Impact factor: 7.396

8.  Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.

Authors:  Lizhong Wang; Tomonori Habuchi; Takeshi Takahashi; Kenji Mitsumori; Toshiyuki Kamoto; Yoshiyuki Kakehi; Hideaki Kakinuma; Kazunari Sato; Akira Nakamura; Osamu Ogawa; Tetsuro Kato
Journal:  Carcinogenesis       Date:  2002-02       Impact factor: 4.944

9.  Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.

Authors:  C Matthias; K Branigan; V Jahnke; K Leder; J Haas; J Heighway; P W Jones; R C Strange; A A Fryer; P R Hoban
Journal:  Clin Cancer Res       Date:  1998-10       Impact factor: 12.531

10.  Alternate splicing produces a novel cyclin D1 transcript.

Authors:  D C Betticher; N Thatcher; H J Altermatt; P Hoban; W D Ryder; J Heighway
Journal:  Oncogene       Date:  1995-09-07       Impact factor: 9.867

View more
  11 in total

1.  Distribution of CCND1 A870G polymorphism in patients with advanced uterine cervical carcinoma.

Authors:  Teresa Warchoł; Lukasz Kruszyna; Margarita Lianeri; Andrzej Roszak; Paweł P Jagodziński
Journal:  Pathol Oncol Res       Date:  2010-08-03       Impact factor: 3.201

2.  Cyclin D1 splice variant and risk for non-Hodgkin lymphoma.

Authors:  Sophia S Wang; Wendy Cozen; Richard K Severson; Patricia Hartge; James R Cerhan; Scott Davis; Robert Welch; Nathaniel Rothman; Stephen J Chanock
Journal:  Hum Genet       Date:  2006-06-17       Impact factor: 4.132

3.  Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?

Authors:  Phuong Thu Vu Hoang; Jérôme Ambroise; Anne-France Dekairelle; Jean-François Durant; Valentina Butoescu; Vu Luan Dang Chi; Nghia Huynh; Tan Binh Nguyen; Annie Robert; Christiane Vermylen; Jean-Luc Gala
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

4.  CCND1 G870A polymorphism is associated with toxicity of methotrexate in childhood acute lymphoblastic leukemia.

Authors:  Yao Xue; Liucheng Rong; Na Tong; Meilin Wang; Zhengdong Zhang; Yongjun Fang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Polymorphisms in XPC provide prognostic information in acute myeloid leukemia.

Authors:  Peipei Xu; Baoan Chen; Jifeng Feng; Lu Cheng; Guohua Xia; Yufeng Li; Jun Qian; Jiahua Ding; Zuhong Lu
Journal:  Int J Hematol       Date:  2012-09-12       Impact factor: 2.490

Review 6.  Genetic susceptibility in childhood acute leukaemias: a systematic review.

Authors:  Gisele D Brisson; Liliane R Alves; Maria S Pombo-de-Oliveira
Journal:  Ecancermedicalscience       Date:  2015-05-14

7.  Tumor PHD2 expression is correlated with clinical features and prognosis of patients with HCC receiving liver resection.

Authors:  Li Zhen; Ning Shijie; Zhang Shuijun
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

8.  Genetic association between cyclin D1 polymorphism and breast cancer susceptibility.

Authors:  XiaoRui Li; XiaoQing Huo; WeiWei Li; QingHui Yang; Ying Wang; XiaoChun Kang
Journal:  Tumour Biol       Date:  2014-11-17

Review 9.  Targeting cell cycle regulators in hematologic malignancies.

Authors:  Eiman Aleem; Robert J Arceci
Journal:  Front Cell Dev Biol       Date:  2015-04-09

10.  The sirtuin 3 expression profile is associated with pathological and clinical outcomes in colon cancer patients.

Authors:  Chunyuan Liu; Zonghai Huang; Hong Jiang; Fujun Shi
Journal:  Biomed Res Int       Date:  2014-07-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.